Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Anticancer Research|August 21, 2003
Paclitaxel and vinorelbine combination in advanced inoperable adenocarcinoma of the lung: a phase II studyGeorge P Stathopoulos, Marinos Veslemes, Niki Georgatou, et al.
Anticancer Research|August 17, 2005
Mesothelioma: treatment and survival of a patient population and review of the literatureJohn Stathopoulos, Dimosthenis Antoniou, George P Stathopoulos, et al.
Oncology|July 25, 2007
A multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancerMichail Ignatiadis, Aris Polyzos, George P Stathopoulos, et al.
Oncology Reports|November 18, 2004
Long-term survival of patients with advanced colorectal cancer may not be due to the response to chemotherapyGeorge P Stathopoulos, Sotiris K Rigatos, Nicos A Malamos, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2006
A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimensChristos Kosmas, Nicolas Tsavaris, Konstantinos Syrigos, et al.
Anti-Cancer Drugs|December 17, 2009
Myelotoxicity of oral topotecan in relation to treatment duration and dosage: a phase I studyGeorge P Stathopoulos, Alexandros Ardavanis, Pavlos Papakotoulas, et al.
Oncology Reports|August 4, 2005
Response to radiotherapy in brain metastases and survival of patients with non-small cell lung cancerDimosthenis Antoniou, Kostas Kyprianou, George P Stathopoulos, et al.
Oncology Reports|September 25, 2008
Comparison of cisplatin-paclitaxel combination versus cisplatin-etoposide in patients with small-cell lung cancer: a Phase III studyJohn Dimitroulis, Angeliki Rapti, George P Stathopoulos, et al.
Human Mutation|December 26, 2001
BRCA2 gene mutations in Greek patients with familial breast cancerAthanasios Armakolas, Angela Ladopoulou, Irene Konstantopoulou, et al.
Anti-Cancer Drugs|May 29, 2004
Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG)Jim Janinis, George P Stathopoulos, Pavlos Nikolaidis, et al.
Pageof 5